Financial Advocates Investment Management Vista Gen Therapeutics, Inc. Transaction History

Financial Advocates Investment Management

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$0.09 - $4.8 $2,078 - $110,865	23,097 New	23,097 $2,000
Q3 2021 Nov 04, 2021	BUY	$2.62 - $3.45 $60,514 - $79,684	23,097 New	23,097 $63,000
Q2 2021 Aug 03, 2021	SELL	$1.96 - $3.15 $45,270 - $72,755	-23,097 Closed	0 $0
Q1 2018 May 11, 2018	BUY	$0.91 - $1.73 $21,018 - $39,957	23,097 New	23,097 $21,000

27.1K

Ticker VTGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 206,836,000
Market Cap $534M
Description
VistaGen Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in developing and commercializing various medicines with the potential to care for anxiety, depression, and other disorders of the central nervous system (CNS). The company's CNS pipeline includes PH94B, a rapid-onset neuroactive nasal spray, which is in Phase III d...

Get notified when there are updates to the investment portfolio of Financial Advocates Investment Management, based on Form 13F filings with the SEC.

Stay updated on Financial Advocates Investment Management with notifications on news.